PanTheryx, Inc.

Boulder, CO · Founded 2007 · CIK 0001416162 · Biotech · Private

Bovine colostrum-based nutritional and health products derived from biotechnology processing

pantheryx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$84M
7 Form D · Oct 2023
36 months since last filing
Contracts
—
No federal contracts on record
Patents
19
2 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$180,000
Private capital raisedForm D · SEC$1,566,100
Private capital raisedForm D · SEC$1,439,858
Private capital raisedForm D · SEC$8,861,523
Private capital raisedForm D · SEC$10,711,756
Private capital raisedForm D · SEC$9,437,369
Private capital raisedForm D · SEC$52,289,052
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1942AXIOMX INC——
1943Sparrow Pharmaceuticals—$73M
1944Iviva Medical—$2.0M
1945PanTheryx, Inc.—$84M
1946Vero Biotech Inc.—$84M
1947RAKTA THERAPEUTICS, INC.——
1948IGF Oncology, LLC—$2.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 28 related persons
  • David AbramsonDirector
  • Mark BramanDirector · Executive Officer
  • MARK BRAMANDirector · Executive Officer
  • David CogutDirector
  • Craig CogutDirector
  • David CookDirector
  • DAVID COOKDirector
  • Peter EricksonDirector
  • Thomas FeeleyExecutive Officer
  • N HarrisDirector
  • James HauExecutive Officer
  • Scott HymanExecutive Officer
  • Holger LiepmannDirector
  • Chris LindsayExecutive Officer
  • Mehmet OzDirector
  • Wes ParrisDirector · Executive Officer
  • THOMAS SCHULTZExecutive Officer
  • Rajiv ShahDirector
  • George StagnittiExecutive Officer
  • Timothy StarzlDirector · Executive Officer
  • Bimla StarzlExecutive Officer
  • TIM STARZLDirector · Executive Officer · Promoter
  • BIMLA STARZLExecutive Officer
  • Gary ThomasExecutive Officer
  • Feeley TomExecutive Officer
  • Peter VitulliDirector
  • Thomas WashingDirector
  • THOMAS WASHINGDirector

Patents

USPTO · 2 granted of 19
  • Compositions For Management Of Disorders Of The Gastrointestinal Tractgranted
  • Stabilized Colostrum Compositionsapplication
  • Methods And Compositions For Reducing Gut Ischemia/reperfusion-induced Injuryapplication
  • Compositions And Methods For Treatment In Broad-spectrum, Undifferentiated Or Mixed Clinical Applicationsapplication
  • Compositions And Methods For Treatment In Broad-spectrum, Undifferentiated Or Mixed Clinical Applicationsgranted
  • Compositions For Management Of Disorders Of The Gastrointestinal Tractapplication
  • Compositions And Methods For Decreasing Passage Of Intestinal Bacteria, Bacterial Products, And Gut Luminal Toxic Contents Through The Gut Wall With Particular Relevance For Sibo And Leaky Gutapplication
  • Medical Nutrition Product Composition For Acute Diarrheaapplication
  • Compositions For Management Of Disorders Of The Gastrointestinal Tractapplication
  • Compositions For Management Of Disorders Of The Gastrointestinal Tractapplication
  • Methods And Compositions For Reducing Gut Ischemia/reperfusion-induced Injuryapplication
  • Compositions For Management Of Disorders Of The Gastrointestinal Tractapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.